Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis
Objective Statins, a class of 3-hydroxy-3 methyl-glutaryl-coenzyme A reductase inhibitors, are widely used for the treatment of atherosclerosis. Less is known about the role of statins in the treatment of vascular complication in systemic sclerosis (SSc). We therefore performed a short-term interven...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-05-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/0300060518762681 |